Found: 17
Select item for more details and to access through your institution.
Synthetic peptide allergy vaccine shows efficacy.
- Published in:
- Nature Biotechnology, 2013, v. 31, n. 5, p. 371, doi. 10.1038/nbt0513-371a
- By:
- Publication type:
- Article
Fresh from the biotech pipeline-2012.
- Published in:
- Nature Biotechnology, 2013, v. 31, n. 2, p. 100, doi. 10.1038/nbt.2498
- By:
- Publication type:
- Article
First novel anti-tuberculosis drug in 40 years.
- Published in:
- Nature Biotechnology, 2013, v. 31, n. 2, p. 89, doi. 10.1038/nbt0213-89
- By:
- Publication type:
- Article
Newsmaker: Constellation Pharmaceuticals.
- Published in:
- Nature Biotechnology, 2010, v. 28, n. 10, p. 997, doi. 10.1038/nbt1010-997
- By:
- Publication type:
- Article
The lengthening handshake.
- Published in:
- Nature Biotechnology, 2010, v. 28, n. 3, p. 197, doi. 10.1038/nbt0310-197
- By:
- Publication type:
- Article
Brand biologics grab 12 years' exclusivity, for now.
- Published in:
- Nature Biotechnology, 2009, v. 27, n. 8, p. 677, doi. 10.1038/nbt0809-677
- By:
- Publication type:
- Article
Masters of their universe.
- Published in:
- Nature Biotechnology, 2009, v. 27, n. 6, p. 528, doi. 10.1038/nbt0609-528
- By:
- Publication type:
- Article
US regulator wades into stem cell therapies for heart disease.
- Published in:
- Nature Biotechnology, 2009, v. 27, n. 6, p. 496, doi. 10.1038/nbt0609-496c
- By:
- Publication type:
- Article
FDA on warpath for Google links.
- Published in:
- Nature Biotechnology, 2009, v. 27, n. 5, p. 405, doi. 10.1038/nbt0509-405
- By:
- Publication type:
- Article
Buzz around Campath proof-of-concept trial in MS.
- Published in:
- Nature Biotechnology, 2009, v. 27, n. 1, p. 6, doi. 10.1038/nbt0109-6
- By:
- Publication type:
- Article
FDA cracks down on labeling, initiates trial result reporting.
- Published in:
- Nature Biotechnology, 2008, v. 26, n. 11, p. 1203, doi. 10.1038/nbt1108-1203
- By:
- Publication type:
- Article
Ark floats gene therapy's boat, for now.
- Published in:
- Nature Biotechnology, 2008, v. 26, n. 10, p. 1057, doi. 10.1038/nbt1008-1057
- By:
- Publication type:
- Article
Myriad stumbles, Wyeth closes on Alzheimer's.
- Published in:
- Nature Biotechnology, 2008, v. 26, n. 8, p. 841, doi. 10.1038/nbt0808-841
- By:
- Publication type:
- Article
FDA and surrogate endpoints in Alzheimer's disease.
- Published in:
- Nature Biotechnology, 2008, v. 26, n. 8, p. 843, doi. 10.1038/nbt0808-843
- By:
- Publication type:
- Article
Commercial interest waxes for IGF-1 blockers.
- Published in:
- Nature Biotechnology, 2008, v. 26, n. 7, p. 719, doi. 10.1038/nbt0708-719
- By:
- Publication type:
- Article
The special treatment.
- Published in:
- Nature Biotechnology, 2008, v. 26, n. 5, p. 487, doi. 10.1038/nbt0508-487
- By:
- Publication type:
- Article
First-in-class insomnia drug on the brink of approval nod.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 7, p. 492, doi. 10.1038/nrd4067
- By:
- Publication type:
- Article